TL
Tilray Brands, Inc.
TLRY · NASDAQ
$4.21 -2.77% (-$0.12)
1M -10.04%
Market Cap $470.8M
P/E Ratio -
Div. Yield -
ROE 7.95%
Piotroski F-Score Weak
3/9Valuation
44 /100
Fair P/S 0.41x
P/B 0.29x
EV/EBITDA 39.67x
Growth
26 /100
Declining Book val. growth 28.77%
Rev. growth 2.72%
FCF growth N/A
Profitability
10 /100
Weak Net margin 12.90%
Op. margin 5.18%
FCF margin 9.87%
Quality
6 /100
Poor ROE 7.95%
ROA 6.40%
Asset turnover 0.50x
Debt
45 /100
Moderate Current ratio 2.21x
Int. coverage -2.31x
Net debt/EBITDA 10.63x
Stability
15 /100
Unstable Rev. volatility 23.02%
EPS volatility 428.66%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na TLRY
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Irwin David Simon
Employees
3,595
Headquarters
Leamington
Nadcházející události
08 ŘÍJ
Earnings
Upcoming earnings report